Your browser doesn't support javascript.
loading
Extracellular vesicles from symbiotic vaginal lactobacilli inhibit HIV-1 infection of human tissues.
Ñahui Palomino, Rogers A; Vanpouille, Christophe; Laghi, Luca; Parolin, Carola; Melikov, Kamran; Backlund, Peter; Vitali, Beatrice; Margolis, Leonid.
Afiliação
  • Ñahui Palomino RA; Section on Intercellular Interaction, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, 20814, USA.
  • Vanpouille C; Section on Intercellular Interaction, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, 20814, USA.
  • Laghi L; Center of Foodomics, Department of Agro-Food Science and Technology, University of Bologna, Cesena, 47123, Italy.
  • Parolin C; Department of Pharmacy and Biotechnology, University of Bologna, Bologna, 40126, Italy.
  • Melikov K; Section on Membrane Biology, Laboratory of Cellular and Molecular Biophysics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, 20814, USA.
  • Backlund P; Biomedical Mass Spectrometry Core Facility, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, 20814, USA.
  • Vitali B; Department of Pharmacy and Biotechnology, University of Bologna, Bologna, 40126, Italy.
  • Margolis L; Section on Intercellular Interaction, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, 20814, USA. margolis@helix.nih.gov.
Nat Commun ; 10(1): 5656, 2019 12 11.
Article em En | MEDLINE | ID: mdl-31827089
The vaginal microbiota, dominated by Lactobacillus spp., plays a key role in preventing HIV-1 transmission. Here, we investigate whether the anti-HIV effect of lactobacilli is mediated by extracellular vesicles (EVs) released by these bacteria. Human cervico-vaginal and tonsillar tissues ex vivo, and cell lines were infected with HIV-1 and treated with EVs released by lactobacilli isolated from vaginas of healthy women. EVs released by L. crispatus BC3 and L. gasseri BC12 protect tissues ex vivo and isolated cells from HIV-1 infection. This protection is associated with a decrease of viral attachment to target cells and viral entry due to diminished exposure of Env that mediates virus-cell interactions. Inhibition of HIV-1 infection is associated with the presence in EVs of several proteins and metabolites. Our findings demonstrate that the protective effect of Lactobacillus against HIV-1 is, in part, mediated by EVs released by these symbiotic bacteria. If confirmed in vivo, this finding may lead to new strategies to prevent male-to-female sexual HIV-1 transmission.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vagina / Infecções por HIV / HIV-1 / Fármacos Anti-HIV / Vesículas Extracelulares / Lactobacillus Limite: Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vagina / Infecções por HIV / HIV-1 / Fármacos Anti-HIV / Vesículas Extracelulares / Lactobacillus Limite: Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article